Log In
Print this Print this

Viaskin HDM

  Manage Alerts
Collapse Summary General Information
Company DBV Technologies S.A.
DescriptionProteins delivered epicutaneously Viaskin patch technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat house dust mite allergy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today